Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Incos AB in connection with the sale of Scandinanvian Cosmetics AB
Mandate

Vinge advises Incos AB in connection with the sale of Scandinanvian Cosmetics AB

June 22, 2011

Vinge has advised the seller, Incos AB, in connection with the sale of Scandinavian Cosmetics AB together with its wholly owned subsidiary, BeautyCos AB, to the Valoras Group, which is listed in Switzerland.

Scandinavian Cosmetics AB and BeautyCos AB are Sweden's leading distributors of cosmetics, fragrances, skincare and haircare products. The companies market approximately 40 world leading trademarks within the beauty industry. The product portfolio includes Max Factor, Olay, Clarins, Kanebo/Sensai, Hugo Boss, Lacoste, Puma, Gucci, Escada, Bvlgari and Björn Axén. The companies have approximately 100 employees at offices in Malmö and Stockholm. In May this year, Scandinavian Cosmetics was awarded "Entrepreneur Company (South) 2011".

Vinge was the sole adviser and project manager in respect of the entire transaction. Vinge's team consisted of, among others, client relationship partner Lars Gildés and associates Christian Lindhé and Karolina Tjärnberg.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025